Noriko Terada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Noriko Terada has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Hiromitsu Negoro
Department of Urology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
1 shared publication - Hiroshi Shimada
Department of Obstetrics and Gynecology, University of Colorado Anschutz, Aurora, CO 80045, USA
1 shared publication - Kazuya Yoshimura
Department of Food and Nutritional Science, College of Bioscience and Biotechnology, Chubu University , Kasugai, Aichi 487-8501, Japan
1 shared publication - Koji Matsumoto
Department of Medical Oncology, Hyogo Cancer Center, Akashi, Japan
1 shared publication - Kyoko Isoyama
Department of Gynecology, Sapporo Medical University, Sapporo, Japan
1 shared publication - Masahiro Suzuki
Department of Obstetrics and Gynecology, Obihiro Kyokai Hospital, Hokkaido, Japan
1 shared publication
Latest Publications
- 11 September 2022
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 27 (11) , 1742-1749
Human papillomavirus testing and cytology using physician-collected uterine cervical samples vs. self-collected vaginal samples and urine samples
Background Human papillomavirus (HPV) testing using self-collected vaginal samples and urine samples is convenient and effective for improving the screening rate. But, to serve as an alternative cervical cancer screening technique, such tests must offer sensitivity equivalent to the HPV testing of physician-collected cervical samples. To examine the effectiveness of HPV testing using self-collected samples and urine samples, we compared the results of HPV testing using these samples with those of HPV testing using physician-collected samples and cytological examinations. Methods The study population included 300 women (age: 20–50 years) with abnormal cervical cytology. The results of HPV testing using self-collected samples and urine samples and physician-collected samples and cervical cytology were compared. Results For all HPV types, the κ-value was 0.773 for physician- and self-collected samples and 0.575 for physician-collected and urine samples. The κ-value for HPV type 16-positive samples was 0.988 for physician- and self-collected samples and 0.896 for physician-collected and urine samples. The κ-value for HPV type 18-positive samples was 0.856 for physician- and self-collected samples and 0.831 for physician-collected and urine samples. For other HPV types, the value was 0.809 for physician- and self-collected samples and 0.617 for physician-collected and urine samples. Conclusions The obtained results were consistent between physician- and self-collected samples as well as between physician-collected and urine samples. Considering that the agreement rate was particularly high for the high-risk HPV types 16 and 18, HPV testing using physician-collected samples, self-collected samples, and urine samples was equally effective for the types with high carcinogenicity.
- 11 September 2022
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 27 (11) , 1742-1749
Human papillomavirus testing and cytology using physician-collected uterine cervical samples vs. self-collected vaginal samples and urine samples
Background Human papillomavirus (HPV) testing using self-collected vaginal samples and urine samples is convenient and effective for improving the screening rate. But, to serve as an alternative cervical cancer screening technique, such tests must offer sensitivity equivalent to the HPV testing of physician-collected cervical samples. To examine the effectiveness of HPV testing using self-collected samples and urine samples, we compared the results of HPV testing using these samples with those of HPV testing using physician-collected samples and cytological examinations. Methods The study population included 300 women (age: 20–50 years) with abnormal cervical cytology. The results of HPV testing using self-collected samples and urine samples and physician-collected samples and cervical cytology were compared. Results For all HPV types, the κ-value was 0.773 for physician- and self-collected samples and 0.575 for physician-collected and urine samples. The κ-value for HPV type 16-positive samples was 0.988 for physician- and self-collected samples and 0.896 for physician-collected and urine samples. The κ-value for HPV type 18-positive samples was 0.856 for physician- and self-collected samples and 0.831 for physician-collected and urine samples. For other HPV types, the value was 0.809 for physician- and self-collected samples and 0.617 for physician-collected and urine samples. Conclusions The obtained results were consistent between physician- and self-collected samples as well as between physician-collected and urine samples. Considering that the agreement rate was particularly high for the high-risk HPV types 16 and 18, HPV testing using physician-collected samples, self-collected samples, and urine samples was equally effective for the types with high carcinogenicity.
- 24 April 2014
- Published by Elsevier in European Urology Supplements
- Vol. 13 (1) , e1102-e1102b
1102 Guideline adherence of immediate post-TUR intravesical chemotherapy for patients with non-muscle invasive bladder cancer
- 24 April 2014
- Published by Elsevier in European Urology Supplements
- Vol. 13 (1) , e1102-e1102b
1102 Guideline adherence of immediate post-TUR intravesical chemotherapy for patients with non-muscle invasive bladder cancer